Nancy Albert
Clinical Nurse Specialist · Chesterland, OHNPI 1508985037
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $70,973 of the $113,717 with a category attached, or 62.4%. 21 manufacturers reported payments, led by Lexicon Pharmaceuticals, Inc. at 24.3% of the total. Reporting peaked in 2024 at $35,243 and has fallen 62.3% since, to $13,271 in 2025. Among clinical nurse specialist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $902.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lexicon Pharmaceuticals, Inc.$28K
- AstraZeneca$22K
- Merck$19K
- Lilly USA, LLC$10K
- Abiomed$7K
- Impulse Dynamics (USA) Inc.$6K
- plus $22K from 15 others
Across 5 payments — averaging $18,423 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$50K
- Roche Diagnostics International Ltd$37K
- Novartis$4K
What the payments were for
- Consulting fees$70,97362%
- Speaking & faculty fees$24,49522%
- Grants$5,0754%
- Travel & lodging$9,6528%
- Food & beverage$3,5223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lexicon Pharmaceuticals, Inc. | 22 | $27,647 |
| AstraZeneca | 22 | $21,865 |
| Merck | 32 | $19,285 |
| Lilly USA, LLC | 4 | $9,988 |
| Abiomed | 5 | $6,710 |
| Impulse Dynamics (USA) Inc. | 10 | $6,065 |
| Boehringer Ingelheim | 3 | $5,505 |
| Boston Scientific | 2 | $3,825 |
| Daiichi Sankyo Inc. | 4 | $2,438 |
| Roche Diagnostics Corporation | 2 | $2,388 |
| Sanofi-aventis U.S. LLC | 1 | $2,184 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,500 |
| Bayer | 1 | $1,225 |
| Astrazeneca UK Limited | 2 | $856 |
| Amgen | 1 | $692 |
| Novartis | 4 | $656 |
| Abbott | 3 | $366 |
| Scpharmaceuticals Inc. | 3 | $352 |
| American Regent | 1 | $75 |
| Analog Devices Inc. | 1 | $50 |
| Johnson & Johnson(2 entities) | 2 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inpefa$10,932
- OPTIMIZER$9,888
- FARXIGA$9,384
- JARDIANCE$7,013
- Impella$6,634
- VERQUVO$5,697
- CLINICAL TRIAL PRODUCT$3,825
- INJECTAFER$2,438
- MULTAQ$2,184
- Kerendia$1,225
- OPTIMIZER SMART SYSTEM$1,000
- ENTRESTO$487
- FUROSCIX$265
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$211
- CARDIOMEMS$155
- LEQVIO$107
How this compares
$113,717 in reported general payments places this provider in the 95th percentile of 97 clinical nurse specialist providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 37 | $41,146 |
| JardianceEmpagliflozin | 16 | $18,258 |
| Metoprolol Succinate | 27 | $611 |
| Rosuvastatin Calcium | 15 | $343 |
| Spironolactone | 37 | $213 |
| Carvedilol | 19 | $153 |
| Lisinopril | 14 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $656 | $41,14637 claims |
| Boehringer IngelheimJardiance | $5,505 | $18,25816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 97 clinical nurse specialist providers in Ohio.
Other clinical nurse specialist in Chesterland
- Frank GargaszBoardman$37K
- Jennifer WoodsAkron$19K
- Nancy BairCleveland$13K
- Maria HeldCleveland$7K
- Rebecca ThomasAkron$6K
- Marie NameyCleveland$5K
- Nancy Hampton-JonesDayton$5K
- Linda DebalzoBeachwood$4K
- Kimberly SprottColumbus$4K
- Deborah BrayCincinnati$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.